Multiple studies have pointed out that landscape of GBM mutations vary to such an extent that RTK/RAS/PI3K alterations have been detected in 83% of samples, the TP53 alterations in 87%, and the RB1 alterations in 78% of the samples. Here, RB1 is linked to glioblastoma.